Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection
Journal of Experimental Medicine · 04.11.2024 · 221 (11)
DOI: 10.1084/jem.20241091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 28.10.2024. Verfasst von Weiwei Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of MGH, MIT and Harvard , Cambridge, MA, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Immunity, Innate. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Antiretroviral treatment (ART) initiation during the early stages of HIV-1 infection is associated with a higher probability of maintaining drug-free viral control during subsequent treatment interruptions, for reasons that remain unclear. Using samples from a randomized-controlled human clinical trial evaluating therapeutic HIV-1 vaccines, we here show that early ART commencement is frequently associated with accelerated and efficient selection of genome-intact HIV-1 proviruses in repressive chromatin locations during the first year after treatment initiation. This selection process was unaffected by vaccine-induced HIV-1-specific T cell responses. Single-cell proteogenomic profiling demonstrated that cells harboring intact HIV-1 displayed a discrete phenotypic signature of immune selection by innate immune responses, characterized by a slight but significant upregulation of HLA-C, HLA-G, the IL-10 receptor, and other markers involved in innate immune regulation. Together, these results suggest an accelerated immune selection of viral reservoir cells during early-treated HIV-1 infection that seems at least partially driven by innate immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ragon Institute of MGH, MIT and Harvard , Cambridge, MA, USA.
- Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA.
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Department of Infectious Disease, Imperial College and Imperial College NIHR Biomedical Research Centre, London, UK.
ORCID-Profile: Weiwei Sun, Ce Gao, Gregory Takashi Gladkov, Isabelle Roseto, Leah Carrere, Elizabeth M Parsons, Carmen Gasca-Capote, John Frater, Sarah Fidler, Xu G Yu, Mathias Lichterfeld
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIDA NIH HHS
- NIH HHS
- Medical Research Council
- amfAR, The Foundation for AIDS Research
- NIMH NIH HHS
- National Institutes of Health
Zitieren
APA
Sun, W., Gao, C., Gladkov, G. T., Roseto, I., Carrere, L., Parsons, E. M., Gasca-Capote, C., Frater, J., Fidler, S., Yu, X. G., Lichterfeld, M., & RIVER Trial Study Group (2024). Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection. Journal of Experimental Medicine, 221(11). https://doi.org/10.1084/jem.20241091
Vancouver
Sun W, Gao C, Gladkov GT, Roseto I, Carrere L, Parsons EM, et al. Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection. Journal of Experimental Medicine. 2024;221(11). doi:10.1084/jem.20241091
BibTeX
@article{Sun2024,
author = {Sun, Weiwei and Gao, Ce and Gladkov, Gregory Takashi and Roseto, Isabelle and Carrere, Leah and Parsons, Elizabeth M and Gasca-Capote, Carmen and Frater, John and Fidler, Sarah and Yu, Xu G and Lichterfeld, Mathias and RIVER Trial Study Group, RIVER Trial Study Group},
title = {Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {11},
doi = {10.1084/jem.20241091}
}
EUVIMED